Tate & Lyle to Construct Sucralose Plant in Singapore

08 November 2004 00:01  [Source: ICB Americas]

With consumer demand for the no-calorie sweetener Splenda on the rise, Tate & Lyle PLC will invest £97 million ($175 million) in a sucralose manufacturing plant in Singapore.

The Singapore plant is the second sucralose manufacturing site for Tate & Lyle. In February, the company paid $134 million for McNeil Nutritionals’ sucralose manufacturing plant in McIntosh, Ala., and related assets. Tate & Lyle then embarked on two expansions of its McIntosh facility that, upon completion in April 2006, will more than double output.

The Singapore facility will have a capacity two-thirds that of the expanded McIntosh site, though the company declines to comment on the capacity at McIntosh. “By January 2007, we will have more than tripled sucralose manufacturing output compared to the level at the time of the realignment of the Splenda sucralose business in April 2004,” notes Ian Ferguson, chief executive of Tate & Lyle.

The company chose to locate the plant in Singapore based on “attractive tariff structures, availability of a highly skilled workforce, proximity to key markets and the excellent support from the Singapore Economic Development board.”

For the latest chemical news, data and analysis that directly impacts your business sign up for a free trial to ICIS news - the breaking online news service for the global chemical industry.

Get the facts and analysis behind the headlines from our market leading weekly magazine: sign up to a free trial to ICIS Chemical Business.

Printer Friendly